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NK cells detect and eliminate ‘stressed’ cells, for example, fol-lowing infection or malignant transformation1. Because of their ability to respond without prior sensitization, acti-
vation of NK cells needs to be tightly regulated to ensure proper 
immunosurveillance while avoiding hyperactivity that may lead to 
inflammatory or autoimmune disorders. Proper responsiveness is 
mediated through an ‘education’ process during NK cell develop-
ment2. After engagement of inhibitory receptors, NK cells gain full 
reactivity and develop tolerance toward self. NK cell responsive-
ness is further fine-tuned by continuous cues that mature NK cells 
encounter in the periphery. NK cell activation depends on a shift 
in the signaling balance between inhibitory and activating recep-
tors. Under homeostatic conditions, inhibitory signals prevail when 
NK cells interact with peripheral tissues. In response to a cellular 
threat, host cells downregulate MHCI molecules and/or overexpress 
stress-induced or nonself-ligands. Upon encounter of ‘stressed’ tar-
get cells, a lack of signals through the inhibitory receptors and/
or increased stimulation of activating receptors shifts the balance 
toward NK cell activation3. The factors that control the bandwidth 
of the equilibrium between inhibitory and activating cues are not 
completely characterized.
NKG2D and NCR1 are activating receptors expressed on all NK 
cells. They primarily mediate tissue stress surveillance by recogniz-
ing stress-induced self-ligands on target cells4. NCR1 (NKp46) is 
the only member of the NCR family expressed in mice. The role of 
NCR1 and NKG2D in the control of tumors and infection is well 
documented4,5. Beyond its effector functions6, NKG2D is expressed 
from the earliest precursors onward during NK cell development7,8. 
NKG2D-deficient mice have bone marrow (BM) NK cell pro-
genitors that have enhanced proliferation, faster maturation and 
augmented sensitivity to apoptosis9, indicating a role for NKG2D 
signaling in NK cell development. Moreover, as expected, NKG2D 
deficiency results in reduced NK cell responsiveness to target cells 
expressing NKG2D ligands9,10. However, in response to specific acti-
vating stimuli, NKG2D-deficient NK cells display a hyper-reactive 
phenotype in terms of production of the cytokine IFN-γ 9,11 and bet-
ter control mouse cytomegalovirus (mCMV) infection compared 
to NKG2D-sufficient NK cells9. How NKG2D deficiency drives NK 
cell hyper-reactivity is unclear.
The activating receptors NCR1 and NKG2D require adaptors to 
convert signals into the cell. NKG2D associates with the adaptors 
DAP10 or DAP12 (ref. 12), and NCR1 docks the adaptors CD3ζ and 
Fcε Rγ 13. DAP10 has a YxxM motif through which the PI3K and 
Grb2-Vav1-SOS1 are engaged13. CD3ζ , Fcε Rγ and DAP12 possess 
ITAM motifs, whose phosphorylation activates signaling proteins 
Syk and ZAP70, resulting in cytotoxicity and/or cytokine produc-
tion13. It is commonly believed that adaptors with ITAM motifs only 
transduce activating signals. However, increasing evidence shows 
that they can also negatively impact signaling cascades13–15. How 
adaptors of activating NK cell receptors contribute to negative regu-
lation of signaling is mostly unknown.
Here we demonstrate that NKG2D deficiency or blocking of 
NKG2D signaling early during NK cell development caused hyper-
reactivity of the NCR1 receptor, resulting in enhanced control of 
mCMV infection and tumors expressing NCR1 ligands. Deficiency 
of NKG2D or DAP12 resulted in downregulation of CD3ζ and 
ZAP-70 yet stronger signaling after NCR1 stimulation. Ablation 
of NKG2D in immature CD122+NK1.1+NCR1+CD11b−c-Kit− NK 
cells completely abrogated the hyperactive phenotype of NK cells, 
indicating that this regulation occurs early during NK development. 
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The activation of natural killer (NK) cells depends on a change in the balance of signals from inhibitory and activating receptors. 
The activation threshold values of NK cells are thought to be set by engagement of inhibitory receptors during development. 
Here, we found that the activating receptor NKG2D specifically set the activation threshold for the activating receptor NCR1 
through a process that required the adaptor DAP12. As a result, NKGD2-deficient (Klrk1−/−) mice controlled tumors and cyto-
megalovirus infection better than wild-type controls through the NCR1-induced production of the cytokine IFN-γ . Expression of 
NKG2D before the immature NK cell stage increased expression of the adaptor CD3ζ . Reduced expression of CD3ζ in Klrk1−/− 
mice was associated with enhanced signal transduction through NCR1, and CD3ζ deficiency resulted in hyper-responsiveness 
to stimulation via NCR1. Thus, an activating receptor developmentally set the activity of another activating receptor on NK cells 
and determined NK cell reactivity to cellular threats.
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NKG2D-driven regulation of NCR1 signaling was independent 
of conventional education mechanisms. Altogether, these results 
reveal an unknown developmental regulation of one activating NK 
receptor by another, which controls the sensitivity of immune sur-
veillance of tumors and viral infections.
Results
Klrk1−/− NK cells efficiently control tumors negative for NKG2D 
ligands. We addressed whether Klrk1−/− mice, which are NKG2D 
deficient, can control tumors that do not express NKG2D ligands 
using a radiation-induced thymic lymphoma (RITL) model16. 
In this model, mice receive low-dose irradiation early in life and 
develop disease after 3 months. RITL is characterized by expan-
sion of CD4+CD8+ T cells lacking NKG2D ligands (Supplementary 
Fig. 1a,b). When Klrk1−/− and C57BL/6 J mice were exposed to this 
regime, we observed a delay in the onset of disease in Klrk1−/− mice. 
Notably, whereas penetration of RITL was around 80% 7 months 
after irradiation in C57BL/6 J mice, less than half of all Klrk1−/− 
mice developed disease (Fig. 1a). To substantiate this observation, 
C57BL/6 J and Klrk1−/− mice were injected i.v. with B16-F10 (B16) 
melanoma cells, which induce lung metastases after i.v. injection 
or solid tumors when applied subcutaneously17 and do not express 
NKG2D ligands (Supplementary Fig. 1b). We observed a delay in the 
development of disease in Klrk1−/− mice compared to Klrk1+/+ litter-
mates (Fig. 1b and Supplementary Fig. 1c). B16 cells applied subcu-
taneously showed a reduced rate of tumor growth in Klrk1−/− mice 
relative to Klrk1+/+ littermates (Fig. 1c and Supplementary Fig. 1d), 
indicating better control of cancer-cell expansion in Klrk1−/− mice.
Because NKG2D is expressed on subsets of T cells6, we asked 
whether NKG2D deficiency enhanced T cell-mediated control of 
tumors in Klrk1−/− mice. Klrk1fl/fl mice18 were crossed with Cd4Cre 
mice to ablate NKG2D on CD4+ T cells, CD8+ T cells and NKT 
cells (Supplementary Fig. 1e). No differences were observed in the 
survival of Cd4CreKlrk1fl/fl mice and Klrk1fl/fl littermates in the RITL 
model (Supplementary Fig. 1f). In addition, i.v. injection of B16 
cells did not result in survival differences between Cd4CreKlrk1fl/fl 
mice and Klrk1fl/fl littermates (Fig. 1d). However, Klrk1−/− mice in 
which NK cells were depleted by monoclonal antibodies (mAb) 1 d 
before i.v. injection of B16 cells no longer had a survival advantage 
over C57BL/6 J control mice (Fig. 1e). Also, differences in tumor 
growth between Klrk1–/– mice and C57BL/6J controls after s.c. 
injection of B16 cells were lost following NK cell depletion (Fig. 1f). 
NK cells can also limit tumor growth indirectly by controlling T 
cell priming and expansion19,20. Klrk1−/− mice in which depletion 
of CD4+ or CD8+ T cells by mAb started 1 d before i.v. injection 
of B16 cells had prolonged survival in comparison to C57BL/6 J 
mice (Fig. 1g and Supplementary Fig. 1g), indicating that NK cells 
are mediating the survival effect of Klrk1−/− mice independently of 
T cells. Splenic Klrk1−/− NK cells killed B16 target cells with effi-
ciency equal to that of C57BL/6 J NK cells in 4 h (Fig. 1h) and 14 h 
(Supplementary Fig. 1h) in vitro cytotoxicity assays. PMA + iono-
mycin-stimulated splenic NK cells predominantly produced IFN-γ 
(Fig. 1i), a cytokine that promotes tumor surveillance21. Klrk1−/− 
NK cells produced more IFN-γ than Klrk1+/+ NK cells after 24 h in 
co-culture with B16 cells (Fig. 1j). To corroborate this finding in 
vivo, Ifng mRNA was quantified in tumors isolated from C57BL/6 J 
or Klrk1−/− mice 10 d after s.c. injection of B16 cells. Tumors iso-
lated from Klrk1−/− mice had higher expression of Ifng mRNA than 
those from C57BL/6 J mice (Supplementary Fig. 1i). To confirm 
the role of IFN-γ in tumor control, we crossed Ifng−/− mice with 
Klrk1−/− mice and followed the survival of Ifng−/−, Klrk1−/− and 
Klrk1−/−Ifng−/− mice following i.v. injection of B16 melanoma cells. 
Klrk1−/−Ifng−/− mice did not have a survival advantage compared 
to Ifng−/− mice, whereas Klrk1−/− mice did (Fig. 1k), indicating that 
better control of B16 melanoma was mediated by an increased 
capacity of Klrk1−/− NK cells to produce IFN-γ .
Klrk1−/− NK cells have specific hyper-reactivity through NCR1. 
To analyze the impact of NKG2D deficiency on target-cell engage-
ment, we performed a conjugation assay with B16 melanoma22. We 
observed no difference in the amount of NK target cell complexes 
between C57BL/6 J and Klrk1−/− NK cells (Fig. 2a). To test whether 
increased IFN-γ production in Klrk1−/− NK cells resulted from 
enhanced signaling through activating receptors, we stimulated 
splenic NK cells from Klrk1−/− mice or Klrk1+/+ littermates through 
different activating receptors. Engagement of receptors NK1.1, 
DNAM-1, Ly49D or Ly49H by mAb or incubation of NK cells with 
IL-12 and IL-18 cytokines resulted in similar production of IFN-
γ in Klrk1−/− and Klrk1+/+ NK cells (Fig. 2b,c and Supplementary 
Fig. 1j). In contrast, stimulation with mAb against the NCR1 
receptor resulted in a higher percentage of IFN-γ +Klrk1−/− NK cells 
compared to IFNγ +Klrk1+/+ NK cells (Fig. 2b,c). NCR1 expression 
and stimulation-induced degranulation by mAb (Fig. 2d) were 
similar in Klrk1−/− and Klrk1+/+ NK cells. Thus, NKG2D-deficient 
NK cells show hyper-responsiveness to stimulation through the 
NCR1 receptor.
NCR1 is known to have a role in the control of B16 melanoma23,24. 
Labeling with NCR1-Ig fusion proteins25 showed high expression 
of NCR1 ligands on B16 cells (Supplementary Fig. 1k). To inves-
tigate whether NCR1 was involved in the enhanced tumor control 
by Klrk1−/− mice, we used Ncr1GFP/GFP mice, which are deficient in 
NCR1. Ncr1GFP/GFP mice showed reduced survival in comparison to 
C57BL/6 J mice after i.v. injection of B16 melanoma cells (Fig. 2e). 
Klrk1−/− mice showed better survival in comparison to C57BL/6 J 
controls, whereas Klrk1−/−Ncr1GFP/GFP mice had survival comparable 
to that of Ncr1GFP/GFP mice (Fig. 2e). Depletion of NK cells by mAb 
abrogated any difference in survival between all mice (Fig. 2e). 
These results show that the enhanced tumor control in Klrk1−/− 
mice is dependent on NCR1 engagement by NK cells.
Compared to C57BL/6 J mice, Klrk1−/− mice have better 
control of MCMV infection (Supplementary Fig. 2), which is 
NK cell dependent9. To test whether this effect was mediated 
through NCR1, we infected C57BL/6 J, Ncr1GFP/GFP, Klrk1−/− and 
Ncr1GFP/GFPKlrk1−/− mice with ∆m157 MCMV, a mutant strain of 
MCMV lacking ligand for NK cell receptor Ly49H. We used this 
MCMV strain to avoid the Ly49H-mediated control of viral rep-
lication, which may occlude the effects of NCR1 (ref. 26). Klrk1−/− 
mice showed better control of ∆m157 MCMV in the spleen 
compared to all other mice, and this was lost after depletion of NK 
cells by mAb (Fig. 2f). These results show that the enhanced con-
trol of MCMV infection by NKG2D-deficient mice is dependent 
on NCR1 engagement by NK cells.
NKG2D sets NCR1 activation threshold during NK cell devel-
opment. During NK cell development, NKG2D is expressed from 
the Lin−CD117dimSca12+Flt3L−CD127+ cells onwards, which rep-
resents the earliest NK cell committed precursor (pre-pro NK)7. 
Because NKG2D deficiency impacts development of NK cells in 
the bone marrow (BM)9 as well as NK cells effector responses in 
the periphery27,28, we asked whether the hyper-reactivity of Klrk1−/−  
NK cells to NCR1 stimulation was acquired during development or later 
on in mature NK cells in the periphery. We crossed Klrk1fl/fl mice with 
Ncr1Cre mice (Supplementary Fig. 3a) to generate Ncr1CreKlrk1fl/fl  
mice, in which Cre-mediated deletion of Klrk1 occurs in 
CD122+NK1.1+NCR1+CD11b−c-Kit− NK cells7,29. Spleen NK 
cells from Ncr1CreKlrk1fl/fl mice showed comparable production of 
IFN-γ to Klrk1fl/fl litermates after stimulation of NCR1 by mAb in 
vitro (Fig. 3a). We did not observe differences in survival between 
Ncr1CreKlrk1fl/fl mice and Klrk1fl/fl littermates after i.v. injection of 
B16 cells (Fig. 3b). In contrast, a higher percentage of spleen NK 
cells from Klrk1Δ/Δ mice, which had a germline deletion of Klrk1 
and were generated from the cross between deleter (tg-cmvCre)30 
and Klrk1fl/fl mice, produced IFN-γ to NCR1 stimulation by mAb 
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compared to C57BL/6 J control (Supplementary Fig. 3b). These 
results indicate that NKG2D sets the activation threshold for 
NCR1 developmentaly before CD122+ NK1.1+ NCR1+ CD11b− 
c-Kit− NK cells.
Next we tested whether NKG2D played a role during early NK 
cell development in a model independent of genetic modification of 
Klrk1. In Rag1CreEYFPStop-FloxiDTR mice, all cells derived from Rag1+ 
hematopoietic precursors, including T cells, B cells and a large 
fraction of NK cells, expressed EYFP and dipheteria toxin recep-
tor (DTR) upon Cre-mediated deletion of the transcriptional ‘stop’ 
sequence and can be eliminated by diphtheria toxin (DT) injection 
(Supplementary Fig. 3c). Rag1CreEYFPStop-FloxiDTR mice were i.p. 
injected with DT on the first two consecutive days to deplete all NK 
cells originating from the Rag1+ precursors. To inhibit NKG2D sig-
naling on all newly generated NK progenitors, the mice were treated 
from the second day onward with NKG2D-blocking mAb or iso-
type control (Supplementary Fig. 3c), and the receptor responsive-
ness of EYFP+ NK cells was analyzed 2 weeks later. Spleen NK cells 
from Rag1CreEYFPStop-FloxiDTR mice that had received i.v. NKG2D-
blocking mAb showed increased IFN-γ production after stimula-
tion of NCR1 but not following stimulation of NK1.1 or Ly49H by 
mAbs (Fig. 3c), indicating that NKG2D sets the activation threshold 
for NCR1 early in NK cell development.
These observations prompted us to analyze the impact of 
NKG2D deficiency on hematopoiesis. NKG2D deficiency does 
not affect hematopoietic stem cells or more differentiated pre-
cursors such as the common lymphoid and myeloid precur-
sors18,31 (Fig. 3d). However, there was a reduction in the number 
of BM Lin−CD117dimSca12+Flt3L−CD127+ NK progenitors in 
Klrk1−/− mice compared to Klrk1+/+ littermates (Fig. 3d). Further 
analysis of NK cell development revealed an increase in percent-
age of CD122+NK1.1+NCR1−CD11b−c-Kit− and decrease of 
CD122+NK1.1+NCR1+CD11b−c-Kit− NK progenitors in Klrk1−/− 
mice compared to Klrk1+/+ littermates (Fig. 3e and Supplementary 
Fig. 4a). To confirm the role of NKG2D in changing NK progeni-
tors in a second model, we analyzed them in BM of Rag1CreEYFPStop-
FloxiDTR mice 15 d after DT injection and treatment with 
NKG2D-blocking mAb. Similar to Klrk1−/− mice, we observed an 
increase in percentage of CD122+NK1.1+NCR1−CD11b−c-Kit− and 
decrease of CD122+NK1.1+NCR1+CD11b−c-Kit− NK progenitors 
compared to isotype control-treated Rag1CreEYFPStop-FloxiDTR mice 
(Fig. 3f). Together, these results indicate a role of NKG2D in NK cell 
development at the time of NCR1 appearance on NK progenitors.
NKG2D-mediated NK cell-education differs from known 
mechanisms. NK cells that never expressed Rag1 during 
d
0
0
50
100
15 20 25 30 35 40 45
C57Bl/6J
Klrk1–/–
Time (d)
Su
rv
iva
l (%
)
e
9 12 13 14
0
5
10
15
20
C57BL/6J
Klrk1–/–
Time (d)
Tu
m
or
 d
ia
m
et
er
 (m
m)
f g h
i
4:1 2:1 1:1 0,5:1
0
10
20
30
40
C57BL/6J
Klrk1–/–
E:T ratio
Sp
ec
ific
 ly
sis
 (%
)
0
20
40
60
80
100 C57BL/6J
Klrk1–/–
Cy
to
kin
e+
N
K 
ce
lls
 (%
)
j
0
5
10
15
20
25
GM
-CS
F
**
IF
N
-γ
+
 
N
K 
ce
lls
 (%
)
Klrk1+/+
Klrk1–/–
0
0
50
100
20 25 30 35 40
Klrk1–/–
Ifng–/–
Klrk1–/–Ifng–/–
**
Time (d)
Su
rv
iva
l (%
)
k
0
0
50
100
20 25 30 35 40 45
Klrk1fl/fl
CD4Cre Klrk1fl/fl
Time (d)
Su
rv
iva
l (%
)
0
0
50
100
20 25 30 35 40 45
C57BL/6J
***
Klrk1–/–
Time (d)
Su
rv
iva
l (%
)
0
0
50
100
150 200 250 300
*
*
Time (d)
Su
rv
iva
l (%
)
Klrk1–/–
C57BL/6J
10 12 13 14
0
5
10
15
20
Klrk1+/+
*
*
*
Klrk1–/–
Time (d)
Tu
m
or
 d
ia
m
et
er
 (m
m)
cba
0
0
50
100
20 25 30 35
Klrk1+/+
Klrk1–/–
**
Time (d)
Su
rv
iva
l (%
)
105
103
104
105
0
0 104103
NK1.1-PerCP-Cy5.5
IF
N
-γ
-
PE
11.1% 22.1%
Klrk1+/+ Klrk1–/–
TN
F IL-
6
IFN
-γ
Fig. 1 | Better control of B16 melanoma by Klrk1−/− mice is NK cell and IFNγ mediated. (a) Survival curve of C57BL/6 J and Klrk1−/− mice in a model 
of radiation-induced thymic lymphomas. (b–g) Graphs show survival curves (b,e,g) or tumor sizes (c,f) of Klrk1−/− mice and indicated controls after 
injection of B16 cells i.v (b,e,g) or s.c. (c,f). One day prior to tumor inoculation, mice were either untreated (b,c) or received depleting antibodies directed 
against NK cells (e,f) or CD8+ T cells (g). Depletion was repeated every fifth day. (d) Survival curve of Klrk1fl/fl and CD4CreKlrk1fl/fl mice that received B16 
cells i.v. (h) Killing capacity of NK cells from C57BL/6 J or Klrk1−/− mice toward CFSE-labeled B16 cells after 4 h of co-cultivation at indicated effector to 
target (E:T) ratios. (i), Cytokine production by NK cells from C57BL/6 J or Klrk1−/− mice 4 h after stimulation with PMA/ionomycin. (j) IFN-γ production 
by NK cells after co-cultivation of splenocytes from Klrk1+/+ and Klrk1−/− mice with B16 cells. Boxed areas are gated for IFN-γ + cells. (k) Survival curve of 
Ifng−/−, Klrk1−/−Ifng−/− and Klrk1−/− mice after B16 cells i.v. injection. Graphs for tumor experiments (a–g,k; n =  10 mice per group) are representative of 
two independent experiments. Survival curves were analyzed by the Kaplan–Meier model followed by log-rank (Mantel–Cox) test (two-tailed; **P <  0.01, 
*** P <  0.001). Tumor sizes and difference between groups after stimulations were analyzed using two-tailed unpaired t-test (shown mean ±  s.e.m.); 
**P <  0.01. Results in (h,i,j) (n =  5 mice per group) are representative of two independent experiments. (b–d,j) were performed using littermates.
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development showed cell-intrinsic hyper-responsiveness in com-
parison to NK cells generated from Rag1+ progenitors32. We there-
fore asked whether NKG2D promoted NK cell development from 
a Rag1+ progenitor. We generated Klrk1+/+Rag1CreEYFPStop-Flox and 
Klrk1−/− Rag1CreEYFPStop-Flox mice, in which expression of Rag1 
was marked through the expression of EYFP. As shown previ-
ously32, we observed that a higher percentage of EYFP− NK 
cells from Klrk1+/+Rag1CreEYFPStop-Flox mice were Klrg1+ and 
CD11b+ compared to EYFP+ NK cells (Supplementary Fig. 4b). 
We made the same observations in Klrk1−/− Rag1CreEYFPStop-
Flox mice (Supplementary Fig. 4c). However, there were no dif-
ferences in percentages of EYFP+ or EYFP− NK cells between 
Klrk1+/+Rag1CreEYFPStop-Flox and Klrk1−/− Rag1CreEYFPStop-Flox mice 
(Fig. 3g). Furthermore, regardless of EYFP expression, NK cells 
from Klrk1−/−Rag1CreEYFPStop-Flox mice produced more IFN-γ than 
NK cells from Klrk1+/+Rag1CreEYFPStop-Flox mice upon NCR1 stim-
ulation by mAb, whereas responsiveness to NK1.1 was similar 
(Fig. 3h), indicating that NKG2D influences NCR1 signaling 
independently of the Rag-driven developmental pathway.
To investigate the role of Ly49-mediated education in NCR1 sig-
naling, we compared the production of IFN-γ in Ly49I+ to that in 
Ly49I− Klrk1+/+ and Klrk1−/− NK cells following NCR1 stimulation 
by mAb. Klrk1−/− Ly49I+ NK cells produced more IFN-γ in com-
parison to Klrk1+/+ Ly49I− NK cells (Fig. 3i). However, Klrk1−/− NK 
cells produced more IFN-γ compared to Klrk1+/+ NK cells regard-
less of their Ly49I expression (Fig. 3i). Also, there was no difference 
in the frequency of Ly49I+ NK cells between Klrk1−/− and Klrk1+/+ 
cells (Supplementary Fig. 4d). These observations indicate that the 
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threshold for the NKG2D-dependent activation of NCR1 is inde-
pendent of Ly49-mediated education.
SHP-1 plays a role in NK cell education, and SHP-1-deficient 
NK cells are hypo-responsive to MHCI-deficient transplants and 
tumors33,34. To test whether SHP-1 played a role in the NKG2D-
mediated education, we treated Klrk1−/− and Klrk1+/+ spleen NK 
cells in vitro with the SHP-1/2 inhibitor NSC-87877 (ref. 35) and 
then stimulated them through the NCR1 receptor by mAb. SHP-
1/2 inhibition resulted in an increase of IFN-γ production in both 
Klrk1−/− and Klrk1+/+ NK cells. However, production of IFN-γ was 
higher in Klrk1−/− NK cells compared to Klrk1+/+ (Fig. 3i), indicating 
that NKG2D sets the activation threshold for NCR1 independently 
of SHP-1/2.
The NKG2D-DAP12 signaling axis regulates NCR1 activity. To 
investigate the mechanism through which NKG2D regulates the 
activity of NCR1, we focused on the adaptors DAP10 and DAP12 
(ref. 12). We used mice lacking either DAP10 (Hcst−/−) or DAP12 
(Tyrobp−/−). There were no differences in the production of IFN-γ  
between C57BL/6J, Klrk1−/−, Hcst−/− and Tyrobp−/− spleen NK cells 
after stimulation through NK1.1 by mAb (Fig. 4a). Ly49H and 
Ly49D use DAP12 for signal transduction13. IFN-γ production from 
Tyrobp−/−, but not Klrk1−/− or Hcst−/− NK cells was reduced compared 
to C57BL/6J NK cells after stimulation through these receptors 
(Fig. 4a). Notably, after stimulation through NCR1, Tyrobp−/−, but 
not Hcst−/−, NK cells showed an increase in IFN-γ production com-
pared to C57BL/6J controls, similarly to Klrk1−/− NK cells (Fig. 4a). 
Similar observations were made after NCR1 stimulation of spleen NK 
cells from Tyrobp−/− mice and Tyrobp+/+ littermates (Supplementary 
Fig. 5a). When B16 cells were injected i.v. in Klrk1−/−, Hcst−/−, 
Tyrobp−/− and C57BL/6J mice, Tyrobp−/− mice showed prolonged 
survival in comparison to Hcst−/−, C57BL/6J and even Klrk1−/− mice 
(Fig. 4b), indicating that signaling through DAP12 only was impor-
tant for NK cell hyper-reactivity to NCR1 stimulation.
We next questioned whether the hyper-responsiveness of 
DAP12-deficient NK cells was specific for NKG2D or whether 
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it was observed following deletion of any receptor that signals 
through this adaptor. When Klrk1−/−, Ly49H−/− or C57BL/6J 
spleen NK cells were stimulated through NK1.1 or NCR1 by 
mAbs or with the cytokine IL-12, Ly49H−/− NK cells did not show 
increased IFN-γ production after any of these stimulations rela-
tive to C57BL/6J NK cells (Fig. 4c). In mice, NKG2D has a long 
(L) and a short (S) isoform, of which only the latter associates 
with DAP12 (ref. 12). We therefore investigated whether NKG2D-S 
and DAP12 were expressed during early NK cell development in 
wild-type mice. qPCR in sorted CD122+NK1.1−NCR1−CD11b−c-
Kit− and CD122+NK1.1+NCR1−CD11b−c-Kit− BM NK progeni-
tors detected transcripts for the Tyrobp and short isoform of Klrk1, 
whose expression increased from CD122+NK1.1−NCR1−CD11b−c-
Kit− to CD122+NK1.1+NCR1−CD11b−c-Kit− NK progenitors 
(Supplementary Fig. 5b,c). Thus, the NKG2D-mediated control of 
NCR1 signaling occurs through the NKG2D–DAP12 axis early in 
NK cell development.
CD3ζ and ZAP-70 are involved in inhibition of NCR1 signaling. 
Because NCR1 uses CD3ζ and Fcε Rγ for signal transduction36, we 
tested whether the NKG2D-DAP12 axis affects signaling through 
these adaptors. Flow cytometry analysis indicated that expression 
of CD3ζ was reduced in both Klrk1−/− and Tyrobp−/− NK cells in 
comparison to C57BL/6J NK cells, whereas expression of Fcε Rγ was 
comparable in all groups (Fig. 5a,b and Supplementary Fig. 5d,e). 
In addition, expression of ZAP-70, a signaling component down-
stream of CD3ζ , was reduced in Klrk1−/− and Tyrobp−/− spleen NK 
cells relative to C57BL/6J NK cells, whereas expression of the Syk 
kinase, also downstream of CD3ζ , was comparable in all groups 
(Fig. 5a,b and Supplementary Fig. 5e). Immunoblot analysis also 
showed reduced expression of CD3ζ and ZAP-70 in Klrk1−/− spleen 
NK cells compared to C57BL/6 J NK cells (Fig. 5c). In contrast, 
Ncr1CreKlrk1fl/fl spleen NK cells had no alterations in the expres-
sion of CD3ζ or ZAP-70 compared to Klrk1fl/fl NK cells (Fig. 5d). 
Because CD3ζ -deficient mouse spleen NK cells are hyper-respon-
sive to CD16 stimulation15, we asked whether NKG2D and DAP12 
mediated the responsiveness of NK cells to CD16 engagement. 
Klrk1−/− and Tyrobp−/− spleen NK cells showed enhanced IFN-γ 
production following CD16 stimulation compared to C57BL/6J NK 
cells (Supplementary Fig. 5f).
As determined by qPCR, Cd247 or Fcre1g mRNA was similar in 
Klrk1−/− and C57BL/6 J NK cells (Fig. 5e), suggesting altered post-
transcriptional regulation. To identify candidates that might impact 
the expression of CD3ζ and/or ZAP-70, we compared the transcrip-
tome of spleen CD3−NK1.1+NCR1+ NK cells from C57BL/6 J, Klrk1 −/−  
and Tyrobp−/− mice by RNA sequencing. Ninety-four genes were 
differentially expressed between C57BL/6 J and Klrk1−/− NK cells, 
whereas expression of 543 genes was different between Tyrobp−/− 
and C57BL/6 J NK cells (Fig. 6a). We performed qualified cluster 
analysis of genes differentially expressed in Klrk1−/− NK cells ver-
sus C57BL/6 J cells on the basis of data mining of known protein–
protein interactions to establish a potential link with CD3ζ and/or 
ZAP-70 (Supplementary Fig. 6a). Next, we determined which of 
these genes showed a shared expression pattern between Klrk1−/− 
and Tyrobp−/− mice (Fig. 6a,b). Prf, encoding perforin, and Sla, 
encoding adaptor SLAP-1, were identified as potential candidates. 
Using flow cytometry analysis we did not detect a difference in 
perforin protein expression between Klrk1−/− and C57BL/6J spleen 
NK cells (Fig. 6c). SLAP-1 is known to target CD3ζ for degradation 
in thymocytes37. Sla transcripts were upregulated in Klrk1−/− and 
Tyrobp−/− NK cells compared to C57BL/6J NK cells (Fig. 6b). Cell 
surface expression of SLAP-1 on Klrk1−/− NK cells was increased 
compared to C67BL/6J NK cells (Fig. 6c and Supplementary 
Fig. 6b). In addition, expression of SLAP-1 in splenic EYFP+ NK cells 
0
0
50
100
20 25 30 35 40
C57BL/6J
Klrk1–/–
Hcst –/–
Tyrobp–/–
**
Time (d)
Su
rv
iva
l (%
)
b
0
10
20
30
40
50
IF
N
-γ
+
 
N
K 
ce
lls
 (%
)
a NK1.1 Ab
IF
N
-γ
+
 
N
K 
ce
lls
 (%
)
0
5
10
15
***
**
***
Ly49H Ab
IF
N
-γ
+
 
N
K 
ce
lls
 (%
)
0
10
20
30
40
***
**
***
Ly49D Ab
IF
N
-γ
+
 
N
K 
ce
lls
 (%
)
0
20
40
60
*
***
***
***
C57BL/6J
Klrk1–/–
Hcst –/–
Tyrobp–/–
NCR1 Ab
IF
N
-γ
+
 
N
K 
ce
lls
 (%
)
c
0
5
10
15
20
25 NK1.1 Ab
IF
N
-γ
+
 
N
K 
ce
lls
 (%
)
0
2
4
6
8
10 IL-12
IF
N
-γ
+
 
N
K 
ce
lls
 (%
)
0
5
10
15
20
25
** **
C57BL/6J
Klrk1–/–
Ly49h–/–
NCR1 Ab
Fig. 4 | The NKG2D-DaP12 signaling axis regulates NCR1 activity. (a) NK cells from Tyrobp−/−(n =  3 or 4 mice), Hcst−/−(n =  3 or 5 mice), Klrk1−/− (n =  3 
or 5 mice) and C57BL/6 J (n =  3 or 5) mice were stimulated for 4 h through the NK1.1, Ly49H, Ly49D or NCR1 receptor by mAb and IFN-γ production was 
analyzed after 4 h. (b) Survival curves of indicated groups of mice after i.v. injection of B16 cells (Kaplan–Meier model followed by Log-rank (Mantel-Cox) 
test; n =  10 mice per group). (c) NK cells from Ly49h−/− (n =  3 mice), Klrk1−/− (n =  4 mice) and C57BL/6J (n =  4 mice) mice were stimulated through the 
NK1.1 or NCR1 receptor by mAb or with IL-12 cytokines and IFN-γ production was analyzed after 4 h. Shown are representative plots of three (a) or two 
(b,c) experiments. For analysis of a and c ANOVA, with Bonferroni’s post-test correction for multiple comparisons was used. Shown are means ±  s.e.m.  
* P <  0.05, ** P <  0.01, *** P <  0.001.
NaTuRe IMMuNoLoGY | VOL 19 | OCTOBER 2018 | 1083–1092 | www.nature.com/natureimmunology1088
ArticlesNATuRE ImmuNoloGy
from Rag1CreEYFPStop-FloxiDTR mice 15 d after DT injection and treat-
ment with NKG2D-blocking Ab was increased compared to EYFP+ 
NK cells from DT and isotype-treated Rag1CreEYFPStop-FloxiDTR mice 
(Fig. 6d). Next, we asked whether SLAP-1 downregulates CD3ζ in 
NK cells. We observed increased expression of CD3ζ protein in 
spleen NK cells from Sla−/− mice37 compared to wild-type controls, 
whereas expression of NCR1, Fcε Rγ , Syk and ZAP-70 were not 
affected (Fig. 6e and Supplementary Fig. 6c). Thus, NKG2D defi-
ciency results in an increase of SLAP-1 protein in NK cells, which 
reduces the expression of CD3ζ .
In thymocytes, CD3ζ and ZAP-70 mediate activation upon TCR 
stimulation, but they are also important for the shutdown of signal 
transduction through recruitment of proteins involved in proximal 
negative feedback mechanisms15,38. We therefore asked whether 
NCR1 stimulation in Klrk1−/− cells results in enhanced proximal 
signaling. Phosphorylation of Syk, the kinase directly downstream 
of Fcε Rγ , was both increased and prolonged in Klrk1−/− NK cells 
after NCR1 stimulation by mAbs compared to Klrk1+/+ NK cells 
(Fig. 6f). Similar observations were made in Tyrobp−/− cells (Fig. 
6g and Supplementary Fig. 6d). Importantly, phosphorylation of 
PLC-γ , which is a target of Syk, was prolonged in Klrk1−/− NK cells 
compared to Klrk1+/+ NK cells, whereas maximal phosphorylation 
of PLC-γ was only slightly increased (Fig. 6h), indicating a reduced 
negative feedback loop in proximal NCR1 signaling. Finally, we 
asked whether CD3ζ deficiency resulted in hyper-responsive NK 
cells. Cd247−/− spleen NK cells produced more IFN-γ after stimula-
tion through the NCR1 receptor by mAb, but not through NK1.1, 
Ly49H or Ly49D, compared to C57BL/6 J spleen NK cells 
(Fig. 6i), indicating a role for CD3ζ in the negative regulation of 
NCR1 signaling. NCR1 expression was similar in all the cells ana-
lyzed (Supplementary Fig. 6f). As such, NKG2D sets an activation 
threshold for the NCR1 receptor by increasing CD3ζ protein and by 
lowering expression of SLAP-1 during NK cell development.
Discussion
Here we show that NKG2D sets activation threshold for NCR1 early 
in NK cell development, which determines the sensitivity of NK 
cells to cellular targets expressing NCR1 ligands. This process oper-
ates through a NKG2D–DAP12 signaling axis that drives down-
regulation of CD3ζ and ZAP-70, involved in negative regulation of 
NCR1 signaling. Thus, we identified a developmental NK cell regu-
lation, distinct from previously described mechanisms of education 
in which one activating receptor regulates the activity of another 
activating receptor.
Our results indicated that the role of NKG2D in the regulation 
of NCR1 activation was mediated by DAP12. Although we did not 
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formally show that NKG2D and DAP12 were directly engaged 
to mediate their regulatory role during NK cell development, the 
absence of a hyper-responsive phenotype in Ly49H-deficient mice 
makes it highly unlikely that these two molecules have an identical 
yet independent effect. The role of DAP12 in setting activat-
ing thresholds does not appear to be unique to NK cells. DAP12-
deficient mice have macrophages39 and pDCs40 that produce higher 
amounts of cytokines after TLR stimulation in comparison to 
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analyzed. Shown are representative plots of one (a,b), two (d,e,i,h) or three (c,f,g) experiments. f and h are performed using littermates. Two-tailed 
unpaired t-test was used to analyze data in c–i. Shown are means ±  s.e.m. * P <  0.05, **P <  0.01, *** P <  0.001.
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wild-type mice. The mechanism by which DAP12 sets activation 
thresholds in these cells is unknown, but it may be similar to the 
NKG2D-mediated regulation in NK cells. Because human NKG2D 
does not bind to DAP12, our findings can not be directly extrapo-
lated. However, several KIRs signal through DAP12 (refs 41–44). 
It has been shown that activating KIRs downmodulate human NK 
cell-responsiveness in individuals carrying self ligands43. It will 
therefore be interesting to see whether regulation of NKp46 activa-
tion thresholds in humans is regulated through NKG2D or through 
Dap12-binding KIRs.
Our data indicated the involvement of CD3ζ and ZAP-70 in the 
negative regulation of NCR1 signaling. NK cells from CD3ζ -deficient 
mice had higher production of IFN-γ after stimulation through the 
NCR1 receptor. These observations are in line with reports of an 
important role for CD3ζ and ZAP-70 in the negative regulation of sig-
naling in T cells38,45 and NK cells15. Following T cell receptor engage-
ment, CD3ζ -ZAP-70 recruit ubiquitinase Nrdp3 and phosphatases 
Sts-1 and Sts-2, which dephosphorylate ZAP-70 and cause cessation 
of the activating signal. Deficiency for Nrdp3, Sts-1 and Sts-2 causes 
prolonged signal transduction46. We observed that Klrk1−/− mice had 
delayed signal inhibition following NCR1 stimulation, especially at 
the level of PLC-γ phosphorylation. Thus, we propose that a reduc-
tion in expression of CD3ζ -ZAP-70 causes impaired recruitment of 
factors that terminate the activating signal directly downstream of 
the NCR1 receptor. Although a direct interaction between CD16 
and CD3ζ has only been shown in human cells, deficiency of CD3ζ 
or DAP12 causes hyper-reactivity in murine NK cells in response 
to CD16 stimulation15,47. We saw increased production of IFN-γ in 
Klrk1−/− NK cells after stimulation through the CD16 receptor, sug-
gesting that NKG2D may also regulate the responsiveness of CD16.
Chronic exposure to NKG2D ligands can result in cross-toler-
ance of multiple distinct NK cell activation pathways27,28. In addi-
tion, weak signaling through NKG2D leads to reduced activity of 
NK cells, which can be circumvented by administration of solu-
ble high-affinity ligands28. However, peripheral ‘desensitization’ 
through NKG2D generates a general hyporesponsiveness of NK 
cells to activating stimuli. Therefore, the developmental and periph-
eral regulation of activation thresholds by NKG2D appear to use 
distinct molecular mechanisms.
The NKG2D-mediated ‘education’ of NCR1 is distinct from 
previously described mechanisms. Education through molecules 
such as Ly49 receptors2 or via modification of the SHP phospha-
tases33 results in a general hyporesponsiveness to activating stimuli. 
The impact of NKG2D-mediated education, in contrast, appears 
restricted to NCR1. Importantly, we identify a temporal window 
in which NKG2D permanently controls NCR1 responsiveness. 
Deletion of Klrk1 from the CD122+NK1.1+NCR1+CD11b−c-Kit− 
NK progenitors onward did not cause NK cell hyperresponsivenes to 
NCR1 as was the case in mice with germline deletion of Klrk1. Ly49 
molecules are expressed from the CD122+NK1.1+NCR1+CD11b−c-
Kit− NK progenitors onward. Indeed, lack of Ly49H, which also 
signals through DAP12, did not result in NK cell hyperresponsive-
ness to NCR1. How permanent regulation of CD3ζ expression by 
NKG2D signaling at a highly restricted stage of NK cell develop-
ment is accomplished mechanistically remains unclear. Our data 
suggest that post-transcriptional regulation of CD3ζ . RNA-seq 
analysis revealed Sla as a candidate involved in this process. Sla 
encodes SLAP-1, an adaptor that targets CD3ζ for ubiquitin ligase 
c-Cbl-dependent degradation following receptor activation37. 
NKG2D deficiency, or blocking of NKG2D during NK cell develop-
ment, caused a permanent increase in Sla gene expression, imply-
ing increased degradation of CD3ζ and subsequently altered signal 
transduction through NCR1. Indeed, SLAP-1-deficient NK cells 
expressed higher amounts of CD3ζ . CD244, another NK activating 
receptor expressed on multipotent hematopoietic progenitors48, was 
shown to regulate immune cell function through epigenetic silencing 
of chromatin regions49. Although methylation analysis of the 
Sla locus in Klrk1−/− NK cells did not reveal differences 
compared to wild-type NK cells (unpublished data by T.D.H. and 
Y.C.B.), this does not exclude another ways of epigenetic regulation 
of Sla expression.
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Methods
Mice. Mice were strictly age and sex matched within experiments and were held in 
SPF conditions and handled in accordance with institutional, national and/or EU 
guidelines. Permission for our experiments was given by Ethical Committee of the 
Faculty of Medicine, University of Rijeka and Croatian Ministry of Agriculture,  
Veterinary and Food Safety Directorate ((UP/I-322-01/16-01/16, 525-10/0255-16-7). 
Mice used in experiments were between 6 and 12 weeks of age. Klrk1−/−, Klrk1fl/fl  
and Klrk1Δ/Δ were generated as described previously9,18. Wild-type C57BL/6 J 
(strain 000664), Balb/c (strain 00651) and Ifng−/− (strain 002287) mice were 
from the Jackson Laboratory. Ncr1GFP/GFP mice were provided by O. Mandelboim 
(Hebrew University Hadassah Medical School). Hcst−/− and Tyrobp−/− mice were 
provided by M. Colonna (St. Louis, MO). Rag1cre/+ mice and were provided by  
M. Busslinger (Vienna, Austria). Rosa26-foxed STOP YFP (EYFPStop-Flox) and iDTR 
mice were provided by A. Waisman (Mainz, Germany). Ncr1Cre and Cd4Cre mice 
were provided by V. Sexl (Vienna, Austria) and D. Littman (New York, NY, USA). 
Deleter-cre mice were kindly provided by K. Rajewsky. Cd247−/− mice were from 
CNRS, Orleans. Sla−/− mice were provided by J. McGlade (Toronto, Canada). 
Klrk1−/− or Tyrobp−/− and wild-type littermates were generated by interbreeding 
heterozygous mice.
Cells. B16 cell line was purchased from the American Type and Culture Collection 
(ATCC). Cells were cultured in complete DMEM, supplemented with 10 mM 
HEPES (pH 7.2), 2 mM l-glutamine, 105 U/L Penicillin, 0.1 g/L Streptomycin, and 
10% FCS. Cells were maintained in an incubator at 37 °C and 5% CO2.
Tumor models. Radiation induced thymic lymphomas. Young mice (4–6 weeks old) 
received low doses of γ radiation (1,6 Gy) once a week for 4 weeks as previously 
described16. In these experiments we used ten mice per group, and experiments 
were repeated two times.
B16 melanoma. Mice received 105 B16 clone F10 (B16) cells i.v or s.c and survival 
(reaching of human end points) or tumor growth, respectively, was followed. 
Digital caliper was used to measure tumor size. X-ray pictures of tumors in 
isolated skin were done using an in vivo imager (MS FX Pro, Carestream) on day 
10 after s.c. tumor inoculation. To deplete lymphocyte populations, mice received 
250 μ g antibodies i.p. 1 d before tumor inoculation and repeated every fifth day. 
Antibodies used were α CD4 (YTS 191.1.2), α CD8 (YTS 169.4.2) and α NK1.1 
(PK136). In these experiments we used ten mice per group and experiments were 
repeated at least two times.
In vitro analysis of NK cells. For NK killer assay, B16 cells were labeled with 
CFSE and co-cultured with C57BL/6 J or Klrk1−/− splenocytes, respectively, at 
an effector to-target ratio adjusted to the number of NK cells. After 4 h or 14 h 
co-culture in a 5% CO2 atmosphere at 37 °C, specific lysis was determined in 
triplicate by flow cytometric analysis as measured by To-pro-3 (To-pro-3 iodide, 
Life technologies) incorporation. Spontaneous death of cells was determined in 
wells containing targets only9. In co-cultivation assays for cytokine production 
analysis, splenocytes from WT or Klrk1−/− mice were co-cultured with B16 cells 
in a 1:1 ratio overnight at 5% CO2 at 37 °C with IL-2 (100 U/mL, R&D Systems), 
IL-12 (50 pg, R&D Systems) and addition of Brefeldin A (eBioscience) for the last 
4 h. IFN-γ production by NK cells was analyzed by flow cytometry. Formation of 
conjugates was done as previously described22. Briefly, B16 cells were CFSE labeled 
and co-cultured with NK1.1-labeled splenocytes. At indicated time points, the 
fraction of CFSE+NK1.1+ double positive cells was determined by flow cytometry. 
For in vitro NK cell stimulations and analysis of cytokine production 5 × 105 
splenocytes were stimulated for 4 h at 5% CO2 atmosphere and 37 °C in addition to 
IL-2 (100 U, Preprotech) and Brefeldin A (eBioscience). For stimulation through 
specific activating receptor 2–5 µ g/mL of antibody in PBS was pre-coated on an 
ELISA plate (α Ly49H (3D10), α Ly49D (4e4), α NK1.1 (PK136), α NCR1 (29A1.4) 
and IgG2aκ (eBM2a)). Cytokines were added in suspension: IL-12 (10 ng/mL, R&D 
Systems) and IL-18 (20 ng/mL, R&D Systems). For SHP-1/2 inhibition we cultured 
cells in the presence of 50 µ M SHP-1/2 PTPase inhibitor (NSC-87877, Merck 
Millipore) dissolved in DMSO, or DMSO only as control. In experiments of in 
vitro NK cell analysis we used five mice per group and experiments were repeated 
two to three times.
Phosphorylation kinetics. Splenocytes were starved from stimuli in RPMI 1640 
for 30 min at 37 °C in a humidified incubator with 5% CO2. Next, cells (5 × 105) 
were stimulated with 2 µ g/mL α NCR1 (29A1.4) for the indicated times. Cells were 
fixed with 2% paraformaldehyde, permeabilized in 90% methanol, and stained with 
p-Syk (Y348) (moch1ct, eBioscience) or p-PLC-γ 1(Y783) (D6M9S, Cell Signaling). 
In these experiments 4–5 mice per group were used and experiment were repeated 
two to three times.
Purification of NK cells and RNA isolation for qPCR. NK cells were enriched 
from splenocytes using biotinylated DX5 antibodies, streptavidin-coated beads 
and magnetic cell sorting (Milteny). Next, NK cells (CD3−NK1.1+) were sorted 
to high (> 99% purity) on a FACS Aria II (BD Biosciences). RNA was isolated via 
the Trizol method, and cDNA was generated with a reverse transcriptase core kit 
(Eurogentec). The expression of mRNA was examined by quantitative PCR analysis 
with a 7500 Fast Real Time PCR machine. Taqman assays were used to quantify 
the expression of Ifng (IFN-γ , Mm00485148_m1). The relative mRNA expression 
was normalized by quantification of Rn18S (18S, Mm03928990_g1) RNA in each 
sample.
RNA-seq. Sorted cells were stored frozen in RLT buffer (Qiagen). Lysates were 
thawed and RNA extracted using column-based purification with the inclusion of 
a DNase I treatment (TurboDNase, Ambion, Thermo Fischer Scientific). Purified 
RNA was converted to cDNA using Superscript II kit with the addition of 20 ng/ml 
anchored Oligo d (T) (Thermo Fischer Scientific) and 1 M Betaine, 12 m M MgCl2 
(Sigma-Aldrich) to aid conversion. Second-strand cDNA synthesis proceeded 
directly using the NEB second strand cDNA synthesis kit (New England BioLabs 
Ltd). The completed cDNA reaction was transferred to a Covaris AFA tube and 
sonicated using 140 W peak power at 200 cycles for 3 min to generate average 
length fragments of 300 bp (Covaris S220, Covaris Inc.). DNA was extracted 
(Micro DNA columns, Qiagen) and used as template in Illuminia compatible 
sequencing library preparation kit (DNA-seq Thruplex, Rubicon Genomics). 
Multiplexed libraries were purified twice using AMPure beads (Becton Coulter 
Inc.) and quantified using Qubit (Thermo Fischer Scientific) and Kapa Library 
Quantification (Kapa Biosystems). Sequencing was performed on a Hi-Seq 3000 
(Illuminia, USA). Sequencing reads were FASTQ quality assessed, trimmed using 
trim galore and mapped to the mm10 mouse genome assembly using STAR-SEQ. 
Differential expression analysis was accomplished using limma and edgeR R 
programmes. For qualified cluster analysis, genes differentially expressed between 
C57BL/6 J and Klrk1 NK cells were analyzed using the String (http://www.String-
db.org) database to identify associations with Zap70 and CD247. Network edges 
with a confidence interval of 0.4 are included, whereas unconnected nodes were 
excluded. Clustering was visualized using Cytoscape 3.5.0 software.
Purification of NK cell precursors and RNA isolation for qPCR. NK precursors 
(stage 1 and stage 2) were sorted according to their expression profiles described 
in supplementary Fig. 4a. Total RNA was extracted using RNeasy Micro Kit 
(Qiagen). The quality of the RNA obtained was evaluated using the Laboratory-
Chip technique (Agilent Bioanalyzer) and subsequently preamplified according 
to the Ambion WTA expression protocol (Thermo Fischer). RNA was reverse 
transcribed into cDNA using the iScript protocol (Bio-Rad). QT-PCR was 
performed using the SsoAdvanced Universal SYBR Green Supermix (Bio-Rad) 
and the MyCycler Thermal cycler system (Bio-Rad).The following primers were 
used: mNKG2D-S FW: AGTTGAGTTGAAGGCTTTGACTC, mNKG2D-S REV: 
ACTTTGCTGGCTTGAGGTC, DAP12 FW: GACTGTGGGAGGATTAAGTCC, 
DAP12 REV: AACACCAAGTCACCCAGAAC.
Flow cytometry. Cells were pretreated with Fc block (clone 2.4G2, produced in-
house). To-pro3 (life Technologies) or Fixable Viability Dye (eBioscience) was used 
to exclude dead cells. Cells were stained and analyzed in PBS containing 1% BSA 
and NaN3 with antibodies listed below. For intracellular staining, permeabilization 
and fixation of cells was done with the Fix/Perm kit (BD Biosciences).The cells 
were measured on a FACSVerse or FACSAria flow cytometer (BD Biosciences), and 
data were analyzed using FlowJo v10 software (Tree Star, Ashland, OR). To analyze 
ligands expression tumor cells were stained with fusion proteins (NKG2D-Fc or 
NCR1-Fc) or irrelevant fusion protein and secondary FITC labeled anti-human 
antibody. For flow cytometry, we used monoclonal antibodies to mouse CD3e  
(145-2C11), NK1.1 (PK136), CD49b (DX5), IFN-γ (XMG1.2), TNFα (MP6-XT22),  
IL-6 (MP5-32C11), GM-CSF (MP1-22E9), NKG2D (CD314) (CX5), CD247 (CD3ζ ) 
(6B10.2), ZAP-70 (1E7.2), CD122 (TM-b1), CD11b (M1/70) and c-kit (CD117)
(ACK2) from eBioscience. Fcε R1γ (1D6) from MBL, CD247 (CD3ζ ) (H146-968) 
from Abcam. Ly49H (3D10) and Ly49D (4e4) were kind gift from W. Yokoyama 
(Washington University in St. Louis, USA). For hematopoietic stem cell staining, 
bone marrow cells were stained with Abs against CD34 (RAM34), Flt3L (A2F10.1), 
CD127 (A7R34), CD16/32 (93), Sca1 (D7), and CD117 (2B8). Populations were 
defined according to previous publication31 as following CLP (CD117dimSca1dimFlt3L
+CD127+),PreProNK (CD117dimSca12+Flt3L−CD127+), MPP (CD117+Sca1+CD34+F
lt3L+), ST-HSC (CD117+Sca1+CD34+Flt3L−), LT-HSC (CD117+Sca1+CD34−Flt3L−), 
CMP (CD117+Sca1−CD34+CD16int), GMP (CD117+Sca1−CD34+CD16+), MEP (CD
117+Sca1−CD34−CD16−). Biotinylated Abs against CD4 (GK1.5), CD8 (53-6.7), 
B220 (RA3-6B2), Gr-1 (RB6-8C5), CD11b (M1/70), TER119 (Ter-119), NK.1.1 
(PK136) were used to exclude Lin+ cells. In experiment where we analyzed 6 stages 
of NK cell development NK1.1 (PK136) was excluded from staining for Lin+ cells· 
Abs were purchased from eBioscience or BD Biosciences. Fusion proteins (NCR1-
Fc, NKG2D-Fc and hPVR-Fc) were produced by our in-house facility.
MCMV infection. The tissue culture grown mCMV MW97.01 and Δm157 MCMV 
was produced in mouse embryonic fibroblasts according to standard protocol. The 
mice were either treated with α NK1.1 (PK136, 250 µ g/mouse) or PBS 24 h before 
i.v. injection of 5 × 105 PFU of Δm157 MCMV. Four days after infection mice were 
sacrificed, and viral titers were determined in spleens by standard virus plaque 
assay. In these experiments 4–5 mice per group were used and experiment were 
repeated two to three times.
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In vivo NKG2D blocking. Rag1CreEYFPStop-FloxiDTR mice were injected i.p. on two 
consecutive days with 0.8 mg diphtheria toxin. From the second day onwards, mice 
received once every 3 d 200 μ g anti-NKG2D (BioXcell, clone HMG2D) or istotype 
control antibodies. After 15 d, spleens and bone marrow were analyzed.
ImmunoBlot. NK cells were enriched from splenocytes using MACS and then 
sorted o high (> 99% purity) on a FACS Aria II (BD Biosciences). Cell extracts 
were generated using laemmli sample buffer (Syk, FcR1γ and Zap 70) or RIPA 
buffer (CD3ζ ), in the presence of protease inhibitors (complete Ultra, Roche). 
Equal amounts of total lysate were analyzed by 12% SDS–PAGE. Proteins were 
transferred to Immobilon-P and incubated with blocking buffer (Tris buffered 
saline/Tween-20) containing 2% low-fat milk for 1 h before incubating with an 
antibody against Syk (Cell Signaling), FcR1γ (Merck Millipore), Zap-70 (Cell 
Signaling) and CD3ζ (Sigma), Akt (Cell signaling) or β -actin (Santa Cruz). 
Bands were visualized with ECL Prime Immuno Blotting Detection Reagent (GE 
Healthcare) using ImageQuant LAS 4000mini (GE Healthcare, Life Science).
Quantitation and statistical analysis. To analyze statistical significance, we used 
Student’s t-test, Mann–Whitney, Kruskal–Wallis and ANOVA, with Bonferroni’s 
post-test correction for multiple comparisons. To assess survival rates, the Kaplan–
Meier model was used followed by log-rank (Mantel–Cox) test for pairwise group 
comparisons. Statistical significance is defined as: * P < 0.05; ** P < 0.01;  
*** P < 0.001.
Reporting Summary. Further information on research design is available in the 
Nature Research Reporting Summary linked to this article.
Data availability
The data that support the findings of this study are available from the 
corresponding author upon request. The NCBI SRA accession codes are: 
SRX4548789, SRX4548788, SRX4548787, SRX4548786, SRX4548785, SRX4548784, 
SRX4548783, SRX4548782, SRX4548781.
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Reporting Summary
Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency and transparency 
in reporting. For further information on Nature Research policies, see Authors & Referees and the Editorial Policy Checklist.
Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main 
text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement
An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one- or two-sided 
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested
A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons
A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND 
variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Give P values as exact values whenever suitable.
For Bayesian analysis, information on the choice of priors and Markov chain Monte Carlo settings
For hierarchical and complex designs, identification of the appropriate level for tests and full reporting of outcomes
Estimates of effect sizes (e.g. Cohen's d, Pearson's r), indicating how they were calculated
Clearly defined error bars 
State explicitly what error bars represent (e.g. SD, SE, CI)
Our web collection on statistics for biologists may be useful.
Software and code
Policy information about availability of computer code
Data collection N.A.
Data analysis Flow Cytometry data analysis was performed using FlowJo software (Tree Star, version 10) 
For qualified cluster  analysis we used String (www.String-db.org)  
Clustering of differentially expressed  genes was visualized using Cytoscape 3.5.0 
 software 
Statistical analysis between groups was performed with GraphPad Prism 5 and 7 
Differential expression analysis was done using  EdgeR 3.14.2 and Limma 3.28.1 
In data analysis MS Excel was also used 
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers 
upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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Data
Policy information about availability of data
All manuscripts must include a data availability statement. This statement should provide the following information, where applicable: 
- Accession codes, unique identifiers, or web links for publicly available datasets 
- A list of figures that have associated raw data 
- A description of any restrictions on data availability
The data that support the findings of this study are available from the corresponding author upon request. The accession codes are: SRX4548789, SRX4548788,  
SRX4548787, SRX4548786, SRX4548785, SRX4548784, SRX4548783, SRX4548782, SRX4548781
Field-specific reporting
Please select the best fit for your research. If you are not sure, read the appropriate sections before making your selection.
Life sciences Behavioural & social sciences  Ecological, evolutionary & environmental sciences
For a reference copy of the document with all sections, see nature.com/authors/policies/ReportingSummary-flat.pdf
Life sciences study design
All studies must disclose on these points even when the disclosure is negative.
Sample size Sample size was determined by power analysis based on pilot experiments and previous findings ( Zafirova et. al.,Immunity 2009.)
Data exclusions No data was excluded
Replication All data was successfully replicated at least two times. How many times each experiment was performed and which statistical analysis was 
used is indicated in the figure legends. 
Randomization Mice were age and sex matched. Mice were allocated to groups by an independent animal caretaker. 
Blinding In our experiments we used mostly genetically modified mice which were genotyped before start of each experiment to determine 
appropriate number of animals per group to ensure statistical power of results for each experiment. However, individual mice and from them 
derived samples were numbered regardless of genotype, which finally allowed blind analysis of samples though. The samples were matched 
with their genotype only after the analysis.
Reporting for specific materials, systems and methods
Materials & experimental systems
n/a Involved in the study
Unique biological materials
Antibodies
Eukaryotic cell lines
Palaeontology
Animals and other organisms
Human research participants
Methods
n/a Involved in the study
ChIP-seq
Flow cytometry
MRI-based neuroimaging
Antibodies
Antibodies used Flow Cytometry: 
Name / Clone name / Catalog no. / (most used) Lot no. / dilution factor / manufacturer  
CD3e/145-2C11/ 45003182/4304569/1:300/eBioscience 
NK1.1/PK136/45594182/l4331619/1:400/eBioscience 
CD49b/DX5/13597183/E03102-1631/1:100/eBioscience 
FNγ/XMG1.2/17731182/4332526/1:200/eBioscience 
TNFα /MP6-XT22/11732181/1927449/1:100/eBioscience 
IL-6/8C9 /21670064/LO144/1:100/Immuno tools 
GM-CSF/MP1-22E9/12-7331-41/E031118/1:100/eBioscience 
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NKG2D (CD314)/CX5/25-5882-82/4275095/1:50/eBioscience 
CD247 (CD3ζ)/6B10.2/12-2479-80/4291757/1:50/eBioscience 
ZAP-70/1E7.2/11-6695-82/4308883/1:400/eBioscience 
CD122 /TM-b1/17-1222-80/E004801633/1:100/eBioscience 
CD11b/M1/70/ 25011281/4289817/1:400/eBioscience 
c-kit (CD117)/ACK2/11-1171-82/E004741631/1:100/eBioscience 
FcεR1γ /1D6/M191-3/ 1:100/MBL 
 CD247 (CD3ζ)/H146-968/ ab91493/6R3198401-1/1:100/ Abcam. 
Ly49H (3D10) and Ly49D (4e4) were kind gift from W. Yokoyama (Washington University in St. Louis, USA)/1:100 
 CD34 /RAM34/14-0341-81/E02497-1631/1:100/eBioscience 
Flt3L /A2F10.1/17-1351-80/E02731-1633/1:100/eBioscience 
CD127 /A7R34/14-1271-82/E014711633/1:100/eBioscience 
CD16/32 /93/14-0161-81/E06356-1631/1:100/eBioscience 
Sca1/D7/17598181/E073531635/1:100/eBioscience 
pSyk(Y348)/moch1ct/12901442/4325047 
pPLCγ(Y786M9S/14008/1:400/Cell Signaling 
Sla/rabbit polyclonal/PA5-22356/TA2506553/1:50/Invitrogen 
Fusion proteins (NCR1-Fc, NKG2D-Fc and hPVR-Fc) were produced by our in-house facility and used 10μg/sample 
 
Western blot: 
Name / Clone name / Catalog no. / (most used) Lot no. / dilution factor / manufacturer 
Syk/D3Z1E/3198/2/1:1000/Cell signaling 
FcR1γ/rabbit polyclonal/06-727/2882662/1:500/ Merckmillipore 
Zap70/99F2/2705/10/1:500/Cell signaling 
CD3ζ /rabbit polyclonal/SAB4503580/210468/1:500/Sigma 
Akt /11E7/4685/6/1:80000/Cell signaling  
β-actin/C4/MAB/2665057/1:80000/Santa Cruz 
Validation Validation of purchased antibodies was done by the suppliers. Data on the validation of in-house generated reagents (fusion 
proteins), has been provided in the supplementary figures. 
Eukaryotic cell lines
Policy information about cell lines
Cell line source(s) The B16-F10 cell line was purchased from ATCC (CRL-6475)
Authentication Authentication was provided by ATCC
Mycoplasma contamination The cell line was confirmed to be negative for mycoplasma contamination by PCR.
Commonly misidentified lines
(See ICLAC register)
No commonly misidentified cell lines were used.
Animals and other organisms
Policy information about studies involving animals; ARRIVE guidelines recommended for reporting animal research
Laboratory animals Mice used in experiments were 6-12 weeks old. Both male and female mice were used but they  were strictly age- and sex-
matched within experiments. 
Klrk1-/- Zafirova et al., 2009. 
Klrk1flox/flox Lenartić et al., 2017. 
Klrk1Δ/Δ Zafirova et al., 2011. 
NCR1gfp/gfp Gazit et al., 2006. 
IFNγ-/- Jackson Laboratories(2287) 
C57BL/6 Jackson Laboratories (B6; strain 664) 
Hcst-/- Laboratory of M. Colonna 
Tyrobp-/- Laboratory of M. Colonna 
Rag1cre/+ Laboratory of M. Busslinger 
Rosa26-foxed STOP YFP Laboratory of Ari Waisman 
NCR1cre Laboratory of V. Sexl 
CD4cre Laboratory of D. Littman 
CD3ζ-/- CNRS, Orleans (B6-Cd3z tm1Mal) 
Deleter-cre (B6.C-Tg(CMV-cre)1Cgn/J) Jackson Laboratories (6054) 
Balb/c Jackson Laboratories (strain 00651) 
Sla-/- Laboratory of Jane McGlade4) 
Wild animals Study did not involve wild animals
Field-collected samples Study did not involve samples collected from the field
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Flow Cytometry
Plots
Confirm that:
The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided.
Methodology
Sample preparation Samples were prepared as described in the methods section. Briefly, animals were sacrificed according to European guidelines 
and spleens and bone marrow were removed. Single cell suspensions were generated by mashing organs through a 70uM sieve 
(spleen) or by smashing bones with a mortar, after which suspensions were run through a sieve. Erythrocytes were lysed using a 
hypotonic solution. Before staining with specific antibodies, cells were pretreated with Fc block (clone 2.4G2, produced in-
house). To-pro3 (life Technologies) or Fixable Viability Dye (eBioscience) was used to exclude dead cells.
Instrument BD FACS ARIA and BD FACS VERSE
Software FlowJo software (Tree Star, version 10)
Cell population abundance After sorting we purity was determined to be 97-99%.   
Gating strategy pecific gating strategies are specified in the figure legends and/or methods section. Briefly, doublets were excluded using FSC-H 
vs. FSC-A gating, followed by SSC-H vs. SSC-A gating. Dead cells were excluded by viability dye. Based on FSC/SSC properties 
gating for lymphocytes was performed. Next, markers for specific cell populations were used to define populations. In most 
experiments, murine NK cells were investigated, which were defined as CD3-NK1.1+ or CD3-NKp46+, depending on the 
experiment and/or genotype of the mice under investigation.  For cytokine production or for specific marker expression, positive 
gates were set based on isotype control, FMO, or on cells genetically deficient for the specified marker (e.g. NKG2D, NCR1, 
CD3zeta). For analysis of haematopoietic precursors in the bone marrow, a lineage channel was used, as well as specific markers 
to define precursor populations. 
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
